Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Feb 2024 15:00

RNS Number : 7504B
GSK PLC
01 February 2024

GSK plc

Total Voting Rights and Capital

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2024 consisted of 4,313,761,992 shares of 31 ΒΌ pence each ('Ordinary Shares'), of which 197,068,169 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,116,693,823. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notifications may be sent to company.secretary@gsk.com.

V A Whyte

Company Secretary

1 February 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TVRBXGDDLSGDGSB
Date   Source Headline
15th Jan 20214:00 pmRNSDirector/PDMR Shareholding
15th Jan 20213:14 pmRNSDirector/PDMR Shareholding
13th Jan 20211:45 pmRNSDirector/PDMR Shareholding
11th Jan 202111:05 amRNSDirector/PDMR Shareholding
11th Jan 20219:16 amRNSDirector/PDMR Shareholding
4th Jan 202111:25 amRNSTotal Voting Rights
30th Dec 202011:52 amRNSDirector/PDMR Shareholding
23rd Dec 20202:44 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSViiV first long-acting HIV regimen approved in EU
11th Dec 20207:00 amRNSSanofi/ GSK update on COVID vaccine candidate
10th Dec 20205:51 pmRNSDirector/PDMR Shareholding
10th Dec 202011:55 amRNSBlock Listing Application
9th Dec 20203:04 pmRNSDirector/PDMR Shareholding
3rd Dec 20205:53 pmRNSDirector/PDMR Shareholding
1st Dec 20203:00 pmRNSTotal Voting Rights
27th Nov 20202:58 pmRNSGSK publishes provisional 2021 dividend dates
26th Nov 202012:35 pmRNSEMTN Supplementary Prospectus
25th Nov 202010:26 amRNSDirector/PDMR Shareholding
23rd Nov 20208:59 amRNSBlock listing Interim Review
19th Nov 20205:40 pmRNSHolding(s) in Company
17th Nov 20205:48 pmRNSDirector/PDMR Shareholding
12th Nov 20201:00 pmRNSMedicago GSK phase 2/3 study start
11th Nov 20203:08 pmRNSDirector/PDMR Shareholding
11th Nov 202011:13 amRNSDirector/PDMR Shareholding
9th Nov 20207:00 amRNSViiV’s cabotegravir superior for HIV prevention
4th Nov 20205:32 pmRNSDirector/PDMR Shareholding
4th Nov 20204:45 pmRNSDirector/PDMR Shareholding
3rd Nov 20204:09 pmRNSDirector/PDMR Shareholding
3rd Nov 20208:00 amRNSGSK sets new environmental goals
2nd Nov 20205:16 pmRNSDirector/PDMR Shareholding
2nd Nov 20203:59 pmRNSTotal Voting Rights
30th Oct 20205:08 pmRNSHolding(s) in Company
30th Oct 202012:53 pmRNSDirector/PDMR Shareholding
28th Oct 20205:46 pmRNSDirector/PDMR Shareholding
28th Oct 202012:00 pmRNS3rd Quarter Results
28th Oct 20207:00 amRNSSanofi and GSK support COVAX - 200m vaccine doses
22nd Oct 202012:34 pmRNSHolding(s) in Company
16th Oct 202012:18 pmRNSPositive CHMP opinion ViiV long-acting HIV regimen
14th Oct 20203:30 pmRNSDirector/PDMR Shareholding
14th Oct 20203:29 pmRNSDirector/PDMR Shareholding
13th Oct 20202:41 pmRNSDirector/PDMR Shareholding
13th Oct 20202:08 pmRNSDirector/PDMR Shareholding
13th Oct 20202:01 pmRNSDirector/PDMR Shareholding
13th Oct 20201:55 pmRNSDirector/PDMR Shareholding
13th Oct 20201:49 pmRNSDirector/PDMR Shareholding
1st Oct 20204:30 pmRNSTotal Voting Rights
22nd Sep 20205:42 pmRNSSanofi/GSK agree up to 72m Canada COVID doses
11th Sep 20203:17 pmRNSDirector/PDMR Shareholding
10th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 20203:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.